601288:SSEAgricultural Bank of China Limited Class A Analysis
Data as of 2026-03-14 - not real-time
CN¥6.62
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Agricultural Bank of China trades at CNY 6.62, comfortably below its 20‑day (CNY 6.61), 50‑day (CNY 6.96) and 200‑day (CNY 6.92) moving averages, suggesting short‑term pressure but also a clear technical gap to the mean. The stock sits just above the calculated support level of CNY 6.33 and below the resistance at CNY 6.83, with a neutral RSI of 44 and a bullish MACD histogram (+0.033) indicating modest upside momentum. Valuation metrics are compelling: a trailing P/E of 8.5 versus an industry average of 16.35, and a price‑to‑book of 0.85, both pointing to a discount relative to peers, while the dividend yield of 3.7% and a modest payout ratio of 31% provide attractive income.
Fundamentally, the bank delivers strong profitability – operating margin of 58% and profit margin of 48% – yet its operating cash flow is negative (‑CNY 1.29 trn), flagging potential asset‑quality concerns. The balance sheet is heavily leveraged with total debt around CNY 5.9 trn, but the reported debt‑to‑equity is zero, reflecting the state‑owned nature of the institution. Market sentiment is in “greed” mode (fear‑greed index 72.9), and trading volume is rising, supporting liquidity.
Fundamentally, the bank delivers strong profitability – operating margin of 58% and profit margin of 48% – yet its operating cash flow is negative (‑CNY 1.29 trn), flagging potential asset‑quality concerns. The balance sheet is heavily leveraged with total debt around CNY 5.9 trn, but the reported debt‑to‑equity is zero, reflecting the state‑owned nature of the institution. Market sentiment is in “greed” mode (fear‑greed index 72.9), and trading volume is rising, supporting liquidity.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical support with bullish MACD signal
- Undervalued relative to industry P/E and P/B
- Increasing volume indicating market interest
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Mean‑reversion potential toward 20‑day SMA
- Attractive dividend yield and sustainable payout
- Continued valuation discount offering upside
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong earnings margins and state‑backed capital base
- Consistent dividend policy supporting total return
- Long‑run upside from sector consolidation and policy support
Key Metrics & Analysis
Financial Health
Revenue Growth5.60%
Profit Margin48.55%
P/E Ratio8.5
ROE9.37%
ROA0.63%
P/B Ratio0.8
Op. Cash FlowCN¥-1287869038592
Industry P/E16.4
Technical Analysis
TrendNeutral
RSI44.0
SupportCN¥6.33
ResistanceCN¥6.83
MA 20CN¥6.61
MA 50CN¥6.96
MA 200CN¥6.92
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
GradeUndervalued
TypeBlend
Dividend Yield3.70%
Risk Assessment
Beta0.07
Volatility19.36%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.